Stellar debut on the stock exchanges, closing 17.23% above the IPO price, reflecting strong investor confidence with the issue being subscribed 63.56 times. The robust listing marks a significant milestone in Akums’ journey of growth and industry
Akums Drugs haceuticals Lt LIS Me Go ONY NSE LISTING CEREM
- Post author:Admin
- Post published:July 21, 2025
- Post category:News & Events
- Post comments:0 Comments


